Organophosphorous pesticides and estrogen induce transformation of breast cells affecting p53 and c-Ha-ras genes

International Journal of Oncology

Volumn 35, Issue 5, 2009, Pages 1061-1068

  Calaf, Gloria M ^a,b   Echiburu Chau, Carlos ^a   Roy, Debasish ^c  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b Department of Medicine   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cells; c Ha ras; Estrogen; Organophosphorous pesticides

Indexed keywords

ESTROGEN; MALATHION; PARATHION; PROTEIN C HA RAS; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL TRANSFORMATION; CHROMOSOME MAP; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; ESTROGENS; FEMALE; GENES, P53; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; MALATHION; MICROSATELLITE INSTABILITY; ORGANOPHOSPHORUS COMPOUNDS; PARATHION; PESTICIDES; POLYMERASE CHAIN REACTION;

EID: 70449674876     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000421     Document Type: Article

References (64)

1. Blair A and Kazerouni N: Reactive chemicals and cancer. Cancer Causes Control 8: 473-490, 1997.
2. Falck F Jr, Ricci A Jr, Wolff MS, Godbold J and Deckers P: Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47: 143-146, 1992.
3. National Cancer Institute: Bioassay of malathion for possible carcinogenicity. Carcinogenesis Technical Report Series No. 24. DHEW Publication No. (NIH) 78-84, 1978.
4. Reynolds P, Hurley SE, Gunier RB, Yerabati S, Quach T and Hertz A: Residential proximity to agricultural pesticide use and incidence of breast cancer in California, 1988-1997. Environ Health Perspect 113: 993-1000, 2005.
5. Andersen HR, Vinggaard AM, Rasmussen TH, Gjermandsen IM and Bonefeld-Jorgensen EC: Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 179: 1-12, 2002.
6. Bennett LM and Davis BJ: Identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagen 39: 150-157, 2002.
7. Brody JG and Rudel RA: Environmental pollutants and breast cancer. Environ Health Perspect 111: 1007-1019, 2003.
8. Henderson BE, Ross R and Bernstein L: Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 48: 246-253, 1988. (Pubitemid 18045752)
9. Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK and Henderson BE: Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem (Suppl) 25: 15-22, 1996. (Pubitemid 27078306)
10. Bernstein L and Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48-65, 1993. (Pubitemid 23269070)
11. Pike MC, Spicer DV, Dahmoush L and Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35, 1993. (Pubitemid 23269068)
12. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in p53 gene occur in diverse human tumor types. Nature 342: 705-708, 1989.
13. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
14. Callahan R: p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84: 826-827, 1992.
15. Russo J, Tahin Q, Lareef MH, Hu YF and Russo IH: Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen 39: 254-263, 2002. (Pubitemid 34260500)
16. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L and Borresen AL: Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68: 540-548, 1993. (Pubitemid 23258459)
17. Smith ML and Fornace AJ Jr: Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol 7: 69-75, 1995.
18. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours (Review). Int J Oncol 7: 413-421, 1995.
19. Zachos G and Spandidos DA: Expression of ras proto-oncogenes: regulation an implications in the development of human tumors. Crit Rev Oncol Hematol 26: 65-75, 1997.
20. Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int J Cancer 103: 730-737, 2003. (Pubitemid 36110228)
21. Barbacid M: Oncogenes in human cancers and in chemically induced animal tumors. Prog Med Virol 32: 86-100, 1985.
22. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987.
23. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989. (Pubitemid 19213607)
24. Spandidos DA and Agnantis NJ: Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Res 4: 269-272, 1984.
25. Matsumoto S, Minobe K, Utada Y, et al: Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer. Cancer Lett 152: 63-69, 2000. (Pubitemid 30169019)
26. Tomlinson IP, Nicolai H, Solomon E and Bodmer WF: The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J Pathol 180: 38-43, 1996. (Pubitemid 26348889)
27. Iida A, Isobe R, Yoshimoto M, Kasumi F, Nakamura Y and Emi M: Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br J Cancer 75: 264-267, 1997. (Pubitemid 27019572)
28. Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993. (Pubitemid 23167611)
29. Thibodeau SN, Bren G and Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260: 816-819, 1993. (Pubitemid 23167612)
30. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993. (Pubitemid 23186645)
31. Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G and Rudzki Z: Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 60: 135-142, 2000.
32. Rennstam K, Baldetorp B, Kytola S, Tanner M and Isola J: Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. Cancer Res 61: 1214-1219, 2001. (Pubitemid 32174445)
33. Soule HD, Maloney TM, Wolman SR, et al: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990. (Pubitemid 20331424)
34. Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993. (Pubitemid 23152785)
35. Calaf GM and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis 21: 769-776, 2000. (Pubitemid 30214035)
36. Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol 77: 31-40, 2001. (Pubitemid 32096694)
37. Calaf GM: Susceptibility of human breast epithelial cells in vitro to hormones and drugs. Int J Oncol 28: 285-295, 2006.
38. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, 1989.
39. Gross-Bellard M, Oudet P and Chambon P: Isolation of high-molecular- weight DNA from mammalian cells. Eur J Biochem 36: 32-38, 1973.
40. Roy D, Calaf G and Hei TK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells. Carcinogenesis 22: 1685-1692, 2001. (Pubitemid 32952148)
41. International Agency for Research on Cancer: Monographs on the evaluation of carcinogenic risks to humans. Vol.30, IARC Scientific Publications, Lyon, pp102-129, 1983.
42. International Agency for Research on Cancer: Monographs on the evaluation of carcinogenic risks to humans. Vols. 1-42, IARC Scientific Publications, Lyon, 1987.
43. Tennant RW, Margolin BH, Shelby MD, et al: Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236: 933-941, 1987.
44. Hour TC, Chen L and Lin JK: Comparative investigation on the mutagenicities of organophosphate, phthalimide, pyrethroid and carbamate insecticides by the Ames and lactam tests. Mutagenesis 13: 157-166, 1998. (Pubitemid 28138300)
45. Amer SM, Fahmy MA, Aly FA and Farghaly AA: Cytogenetic studies on the effect of feeding mice with stored wheat grains treated with malathion. Mutat Res 513: 1-10, 2002.
46. Garaj-Vrhovac V and Zeljezic D: Cytogenetic monitoring of croatian population occupationally exposed to a complex mixture of pesticides. Toxicology 165: 153-162, 2001. (Pubitemid 32778307)
47. Garaj-Vrhovac V and Zeljezic D: Assessment of genome damage in a population of Croatian workers employed in pesticide production by chromosomal aberration analysis, micronucleus assay and Comet assay. J Appl Toxicol 22: 249-255, 2002. (Pubitemid 34830749)
48. Giri S, Prasad SB, Giri A and Sharma GD: Genotoxic effects of malathion: an organophosphorus insecticide, using three mammalian bioassays in vivo. Mutat Res 514: 223-231, 2002. (Pubitemid 34114095)
49. Prakash N, Narayana K, Murthy GS, Moudgal NR and Honnegowda: The effect of malathion, an organophosphate, on the plasma FSH, 17 beta-estradiol and progesterone concentrations and acetylcholinesterase activity and conception in dairy cattle. Vet Hum Toxicol 34: 116-119, 1992.
50. Asmathbanu I and Kaliwal BB: Temporal effect of methyl parathion on ovarian compensatory hypertrophy, follicular dynamics and estrous cycle in hemicastrated albino rats. J Basic Clin Physiol Pharmacol 8: 237-254, 1997. (Pubitemid 28254959)
51. Dhondup P and Kaliwal BB: Inhibition of ovarian compensatory hypertrophy by the administration of methyl parathion in hemicastrated albino rats. Reprod Toxicol 11: 77-84, 1997. (Pubitemid 27152422)
52. Gouda H and Sastry MS: Effect of 0,0-Dimethyl-0 phosphorothicate (sumithion) on reproductive performance in rats and oestrogenic activity in mice. Indian J Pharmacol 11: 287-292, 1979.
53. Bonner MR, Coble J, Blair A, Beane Freeman LE, Hoppin JA, Sandler DP and Alavanja MC: Malathion exposure and the incidence of cancer in the agricultural health study. Am J Epidemiol 166: 1023-1034, 2007. (Pubitemid 47574686)
54. Blasiak J, Jaloszynski P, Trzeciak A and Szyfter K: In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues. Mutat Res 445: 275-283, 1999.
55. Berkman CE, Quinn DA and Thompson CM: Interaction of acetylcholinesterase with the enantiomers of malaoxon and isomalathion. Chem Res Toxicol 6: 724-730, 1993. (Pubitemid 23290027)
56. Calaf GM and Roy D: Gene expression signature of parathion-transformed human breast epithelial cells. Int J Mol Med 19: 741-750, 2007.
57. Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D and Iacopetta B: P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7: 1343-1349, 2001. (Pubitemid 32708690)
58. Samowitz WS, Holden JA, Curtin K, et al: Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 158: 1517-1524, 2001. (Pubitemid 32281315)
59. Mendez O, Manas S, Peinado, Fabra A, Escobedo A, Moreno A and Sierra A: Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas. Breast Cancer Res Treat 65: 171-177, 2001. (Pubitemid 32193621)
60. Zhang PL, Calaf G and Russo J: Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Mol Carcinog 9: 46-56, 1994. (Pubitemid 24061285)
61. Calaf GM, Alvarado ME and Hei TK: Oncoprotein expression and morphological phenotypes of human breast epithelial cells transformed by the c-Ha-ras oncogene. Oncol Rep 14: 885-893, 2005.
62. Enamoto T, Inoue M, Perantoni AO, Buzard GS, Miki H, Tanizawa O and Rice JM: K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 51: 5308-5314, 1991.
63. Duggan BD, Felix JC, Muderspach LI, Tsao JL and Shibata DK: Early mutational activation on the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res 54: 1604-1607, 1994.
64. Schubbert S, Shannon K and Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295-308, 2007. (Pubitemid 46480970)